These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6586449)

  • 1. Pharmacokinetics of almitrine bismesylate: studies in patients.
    Bromet N; Courte S; Aubert Y; Baune A; Balem MP; du Vignaud P
    Eur J Respir Dis Suppl; 1983; 126():363-75. PubMed ID: 6586449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical pharmacokinetics of almitrine dimesylate].
    Bromet N; Singlas E
    Presse Med; 1984 Oct; 13(34):2071-7. PubMed ID: 6149534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic and pharmacokinetic interactions of almitrine bismesylate.
    Campbell DB; Gordon BH; Ings RM
    Rev Mal Respir; 1985; 2 Suppl 1():S39-44. PubMed ID: 2870546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term studies on almitrine bismesylate in COPD patients.
    Bourgouin-Karaouni D; Mercier J; Prefaut C
    Eur J Respir Dis Suppl; 1986; 146():695-701. PubMed ID: 3096767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pattern of breathing and gas exchange following oral almitrine bismesylate in patients with chronic obstructive pulmonary disease.
    Stradling JR; Nicholl CG; Cover D; Davies EE; Hughes JM; Pride NB
    Eur J Respir Dis Suppl; 1983; 126():255-64. PubMed ID: 6373340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and handling of almitrine bismesylate in healthy subjects.
    MacLeod CN; Thomas RW; Bartley EA; Parkhurst GW; Bachand RT
    Eur J Respir Dis Suppl; 1983; 126():275-89. PubMed ID: 6586442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vectarion International Multicentre Study (VIMS): a long term double blind placebo controlled trial in COLD patients.
    Sadoul P
    Eur J Respir Dis Suppl; 1983; 126():357-61. PubMed ID: 6373344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study].
    Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J; Prefaut C
    Rev Mal Respir; 1984; 1(4):245-50. PubMed ID: 6505362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of almitrine bismesylate in acute respiratory failure.
    Lambropoulos S; Chatzipappas A; Tsekos G; Tsantoulis K
    Eur J Respir Dis Suppl; 1986; 146():657-61. PubMed ID: 3465586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biodisposition of almitrine bismesylate in man: a review.
    Campbell DB; Gordon B; Taylor A; Taylor D; Williams J
    Eur J Respir Dis Suppl; 1983; 126():337-48. PubMed ID: 6586447
    [No Abstract]   [Full Text] [Related]  

  • 12. Beneficial effects of almitrine bismesylate on pulmonary gas exchange in COPD.
    Melot C; Naeije R; Hallemans R; Mols P; Lejeune P
    Eur J Respir Dis Suppl; 1983; 126():249-54. PubMed ID: 6586439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of almitrine in healthy volunteers and patients with essential hypertension.
    Wilke A; Siegmund W; Schneider T; Wiersbitzky M; Franke G
    Biomed Biochim Acta; 1991; 50(2):183-7. PubMed ID: 1877979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of peripheral nerve function in hypoxaemic COPD patients taking almitrine bismesylate: a prospective long-term study.
    Lerebours G; Senant J; Moore N; Arnaud F; David P; Ozenne G; Nouvet G
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():203s-206s. PubMed ID: 2825867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of renal insufficiency on the hepatic clearance of some drugs.
    Balant LP; Dayer P; Fabre J
    Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One year administration of almitrine bismesylate (Vectarion) to chronic obstructive pulmonary disease patients: pharmacokinetic analysis.
    Stavchansky S; Doluisio JT; Macleod CM; Szalkowski MB; Bachand RT; Heilman R; Sebree TB; Geary RS
    Biopharm Drug Dispos; 1989; 10(3):247-55. PubMed ID: 2566339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Almitrine per os in the therapy of chronic obstructive bronchopneumopathies].
    Seignalet C; Préfaut C; Gonzales C; Michel FB
    Rev Fr Mal Respir; 1980; 8(6):627-33. PubMed ID: 7027375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VA/Q ratios distribution and oral almitrine bismesylate in COPD patients under mechanical ventilation: preliminary results.
    Castaing Y; Manier G; Guenard H
    Eur J Respir Dis Suppl; 1983; 126():243-7. PubMed ID: 6586438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.